Octapharma AG - Strategic SWOT Analysis Review

Date: June 16, 2015
Pages: 30
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: OE151A78EEDEN
Leaflet:

Download PDF Leaflet

Octapharma AG - Strategic SWOT Analysis Review
Octapharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.

    Highlights

    Octapharma AG (Octapharma) is a pharmaceutical company. It develops, manufactures, and markets human protein therapies derived from human plasma, and human cell-lines. The company focuses on therapeutic areas such as haematology and immunotherapy, and intensive care and emergency medicine. Octapharma markets its products under brand names such as Albuminativ, Albunorm, Atenativ, Aunativ, Gammanorm, Nanofix, Nanotiv, Octafix, Octagam, Octagam 10%, Octanate, Octaninef, Octanyne, Octaplas, Octaplaslg, Octaplex, Octavi SD Optimum, Pronative, Rhesonativ, Uniplas and Wilate. It has six research centers and manufacturing facilities. The company operates through subsidiaries and representative offices in Europe, Asia, Russia, the Middle East, the US, South America, Canada, Mexico, Africa, Australia and New Zealand. Octapharma is headquartered in Lachen, Switzerland.

    The company invests in production facilities with strategic focus on projects to increase plasma fractionation capacity to reach its production goals for 2019. To this end, the company is increasing its capacity in various facilities across the world.

    Octapharma AG Key Recent Developments

    Oct 21, 2013: Octapharma signs long-term strategic supply agreement with Ethicon
    Oct 10, 2013: Octapharma Plasma invests $39.2 million on expansion of U.S. Operation
    Jun 20, 2013: ProMetic Receives $4.8m Purchase Order From Octapharma
    Mar 25, 2013: Octapharma Group release 2012 Annual Report

    Reasons to Buy
    • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
    • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
    • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
    • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
    Note: Some sections may be missing if data is unavailable for the company.
  • SECTION 1 - ABOUT THE COMPANY

    Octapharma AG - Key Facts
    Octapharma AG - Key Employees
    Octapharma AG - Major Products and Services
    Octapharma AG - Pharmaceutical Pipeline Products Data
    Octapharma AG, Pipeline Products by Therapy Area
    Octapharma AG, Pipeline Products by Development Phase
    Octapharma AG - History
    Octapharma AG - Company Statement
    Octapharma AG - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Octapharma AG - Key Manufacturing Facilities

    SECTION 2 – COMPANY ANALYSIS

    Octapharma AG - Business Description
    Octapharma AG - Corporate Strategy
    Octapharma AG - SWOT Analysis
    SWOT Analysis - Overview
    Octapharma AG - Strengths
    Strength - Strong Portfolio of Hematology Products
    Strength - Research and Development
    Strength - Improved Operational Performance
    Octapharma AG - Weaknesses
    Weakness - Patent Infringement Lawsuits
    Octapharma AG - Opportunities
    Opportunity - Medical Need for Hemophilia Treatments
    Opportunity - Entry into Recombinant Technology Market
    Opportunity - Capacity Expansion Initiatives
    Octapharma AG - Threats
    Threat - Product Liability Claims
    Threat - Competitive Pressures
    Threat - Government Regulations
    Octapharma AG - Key Competitors

    SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
    Octapharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
    Octapharma AG, Recent Deals Summary

    SECTION 4 – APPENDIX

    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Octapharma AG, Key Facts
    Octapharma AG, Key Employees
    Octapharma AG, Major Products and Services
    Octapharma AG, Number of Pipeline Products by Therapy Area
    Octapharma AG, Number of Pipeline Products by Development Stage
    Octapharma AG, Pipeline Products By Therapy Area and Development Phase
    Octapharma AG, History
    Octapharma AG, Other Locations
    Octapharma AG, Subsidiaries
    Octapharma AG, Key Manufacturing Facilities
    Octapharma AG, Key Competitors
    Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
    Octapharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
    Octapharma AG, Recent Deals Summary

    LIST OF FIGURES

    Octapharma AG, Pipeline Products by Therapy Area
    Octapharma AG, Pipeline Products by Development Phase
    Octapharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
    Octapharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
    Skip to top


    Ask Your Question

    Octapharma AG - Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: